SkepSkep
Back to rankings
All-In with Chamath, Jason, Sacks & Friedberg — Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
Scout ratingSCOUT· 23%30m·2025-09-29·Technology

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

All-In with Chamath, Jason, Sacks & Friedberg

(0:00) Introducing Eli Lilly CEO Dave Ricks (1:43) How Eli Lilly discovered the GLP-1 impact on weight loss, counterfeit products from China (7:08) GLP-1 pricing and capital allocation after a breakout pharma product (12:56) Why Biotech VC has plummeted, "patent hacking" in China (15:32) Dave's health regimen: good…

Buzzmeter · cross-platform
Scout rating
23%
SCOUT

Scout bees are checking it out — divided opinions, the swarm hasn't committed.

Platform23%
Community23%
Platform × 0.6 + Community × 0.4
Hive Vote · Skep listeners
New on SkepAwaiting the hive's first votes

Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.

Rate this episode

Add your vote to the Hive — listeners rate every episode after they finish.

Rate this episode
Recent reviews
  • No reviews yet — be the first.

Cross-platform signals

The trail of evidence across every platform we track.

Apple Podcasts
Indexed via iTunes LookupRSS feed ingested into Skep

What people are saying

Pulled from RSS feed.

Source: Apple Podcasts